Lucien Perey

1.8k total citations
43 papers, 878 citations indexed

About

Lucien Perey is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Lucien Perey has authored 43 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Lucien Perey's work include Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Immune Cell Function and Interaction (5 papers). Lucien Perey is often cited by papers focused on Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (5 papers) and Immune Cell Function and Interaction (5 papers). Lucien Perey collaborates with scholars based in Switzerland, United States and Italy. Lucien Perey's co-authors include Serge Leyvraz, Donald Küfe, Daniel F. Hayes, Beat Thürlimann, Aron Goldhirsch, V von Fliedner, P. Burckhardt, D. Thiébaud, Carl O’Hara and Miyako Abe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Lucien Perey

43 papers receiving 847 citations

Peers

Countries citing papers authored by Lucien Perey

Since Specialization

Citations

This map shows the geographic impact of Lucien Perey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucien Perey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucien Perey more than expected).

Fields of papers citing papers by Lucien Perey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucien Perey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucien Perey. The network helps show where Lucien Perey may publish in the future.

Co-authorship network of co-authors of Lucien Perey

This figure shows the co-authorship network connecting the top 25 collaborators of Lucien Perey. A scholar is included among the top collaborators of Lucien Perey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucien Perey. Lucien Perey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutations de [i]BRCA1/2[/i] : d’Angelina Jolie à la thérapie 2016 ·Revue Médicale Suisse ·(unknown), Athina Stravodimou, Sheila Unger, Lucien Perey, Khalil Zaman	1
2	Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08 2015 ·European Journal of Cancer ·Khalil Zaman, (unknown), Christoph Mamot, (unknown), Christoph Rochlitz, Andreas Mueller, Catherine Berset, (unknown), Lucien Perey, (unknown), Hanne Hawle, (unknown), Patrick Neven	43
3	A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small Cell Lung Cancer: A Randomized Trial 2008 ·JNCI Journal of the National Cancer Institute ·Serge Leyvraz, S. Pampallona, Giovanni Martinelli, F. Ploner, Lucien Perey, Savina Aversa, Solange Peters, Paal Brunsvig, Ana Fernández Montés, Andrzej Lange, Ufuk Yılmaz, Giovanni Rosti, (unknown)	30
4	Cancer du sein chez la jeune femme: traitements adjuvants et désir de grossesse [Breast cancer in young women: adjuvant therapy and fertility] 2007 ·SERVAL (Université de Lausanne) ·Khalil Zaman, (unknown), Lucien Perey, Wendy Jeanneret‐Sozzi, Jean-François Delaloye, (unknown)	1
5	Randomized phase III study of high-dose sequential chemotherapy (CT) supported by peripheral blood progenitor cells (PBPC) for the treatment of small cell lung cancer (SCLC): Results of the EBMT Random-ICE trial 2006 ·Journal of Clinical Oncology ·Serge Leyvraz, S. Pampallona, (unknown), F. Ploner, Savina Aversa, Giovanni Rosti, Paal Brunsvig, Ana Fernández Montés, Uğur Yılmaz, Lucien Perey	4
6	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00) 2006 ·Annals of Oncology ·Lucien Perey, Robert Paridaens, Hanne Hawle, Khalil Zaman, Franco Nolè, (unknown), Maryse Fiche, D. Dietrich, Patrice Clément, Dieter Köberle, Aron Goldhirsch, Beat Thürlimann	103
7	Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer 2004 ·British Journal of Cancer ·(unknown), Jürg Bernhard, David Zahrieh, AS Coates, Richard D. Gelber, Monica Castiglione‐Gertsch, Elizabeth Murray, John Forbes, Lucien Perey, J. Collins, R. Snyder, (unknown), Diana Crivellari, Andrea Veronesi, Beat Thürlimann, Martin F. Fey, Karen N. Price, Aron Goldhirsch, Christoph Hürny	21
8	Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial 2004 ·Breast Cancer Research and Treatment ·Beat Thürlimann, Dagmar Hess, Dieter Köberle, (unknown), Pierluigi Ballabeni, Olivia Pagani, Lucien Perey, Stefan Aebi, Christoph Rochlitz, Aron Goldhirsch	51
9	Does Subjective Burden of Early Breast Cancer and its Treatment Affect Immune Measures During Adjuvant Therapy? 2004 ·Breast Cancer Research and Treatment ·(unknown), Jürg Bernhard, (unknown), Shu-Fang Hsu Schmitz, (unknown), Beat Thürlimann, Hervé Bonnefoi, Lucien Perey, Richard Herrmann, Aron Goldhirsch, Christoph Hürny	6
10	Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine 2001 ·Oncology ·Roger Stupp, Alexandre Bodmer, B Duvoisin, Jean Bauer, Lucien Perey, (unknown), Nicolas Ketterer, Serge Leyvraz	10
11	High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR 2001 ·British Journal of Cancer ·Lucien Perey, Jean Benhattar, Robert Peters, (unknown), Serge Leyvraz	18
12	Sequential administration of temozolomide and fotemustine: Depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours 1999 ·Annals of Oncology ·(unknown), Serge Leyvraz, Laurent A. Décosterd, Marina Bonfanti, Catia Marzolini, Furao Shen, D. Liénard, Lucien Perey, Gennaro Colella, Jérôme Biollaz, Ferdy J. Lejeune, Daniel B. Yarosh, Michael Belanich, Maurizio D’Incalci	40
13	Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients 1999 ·Supportive Care in Cancer ·(unknown), Monica Castiglione, (unknown), (unknown), M. Bacchi, (unknown), (unknown), (unknown), Lucien Perey, Aron Goldhirsch, H.-J. Senn	13
14	Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials 1998 ·British Journal of Cancer ·Christoph Hürny, (unknown), M. Bacchi, Jürg Bernhard, Beat Thürlimann, (unknown), Lucien Perey, Hervé Bonnefoi, Alan S. Coates	23
15	Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors 1998 ·British Journal of Haematology ·Lucien Perey, (unknown), S. Pampallona, Philippe Schneider, Nicole Groß, Serge Leyvraz	17
16	Expression of the DF3-P epitope in human ovarian carcinomas. 1995 ·PubMed ·(unknown), Lucien Perey, (unknown), F. Buchegger, Donald Küfe	18
17	Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor 1995 ·British Journal of Cancer ·Serge Leyvraz, Nicolas Ketterer, Lucien Perey, Judith Bauer, (unknown), Jean‐Jacques Grob, (unknown), V von Fliedner, Ferdy J. Lejeune, F Bachmann	11
18	Treatment of bone metastases from breast cancer and myeloma with pamidronate 1991 ·European Journal of Cancer and Clinical Oncology ·D. Thiébaud, Serge Leyvraz, V von Fliedner, Lucien Perey, P Cornu, (unknown), P. Burckhardt	63
19	Elevated CA125 levels in patients with metastatic breast carcinoma 1990 ·British Journal of Cancer ·Lucien Perey, (unknown), Carlo Tondini, Guy van Melle, Judith Bauer, (unknown), (unknown), (unknown), Serge Leyvraz	16
20	Treatment of Tumor-Induced Osteolysis by APD 1989 ·Recent results in cancer research ·P. Burckhardt, D. Thiébaud, Lucien Perey, V von Fliedner	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact